BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15355743)

  • 1. Adalimumab in rheumatoid arthritis.
    Moreland L
    Curr Rheumatol Rep; 2004 Oct; 6(5):333-4. PubMed ID: 15355743
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab in rheumatoid arthritis.
    Moreland L
    Curr Rheumatol Rep; 2004 Oct; 6(5):334-5. PubMed ID: 15355744
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of adalimumab in the treatment of early rheumatoid arthritis.
    Keystone EC; Haraoui B; Bykerk VP
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S198-9. PubMed ID: 14969077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab.
    True DG; Penmetcha M; Peckham SJ
    J Rheumatol; 2002 Jul; 29(7):1561-3. PubMed ID: 12136922
    [No Abstract]   [Full Text] [Related]  

  • 5. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
    Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
    Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 8. Leflunomide improves the clinical response in patients with active rheumatoid arthritis treated with methotrexate.
    Van Riel P
    Clin Exp Rheumatol; 2003; 21(6):695-6. PubMed ID: 14740446
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of ingestion of ferrous sulfate on the absorption of oral methotrexate in patients with rheumatoid arthritis.
    Hamilton SF; Campbell NR; Kara M; Watson J; Connors M
    J Rheumatol; 2003 Sep; 30(9):1948-50. PubMed ID: 12966595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of infliximab in the treatment of early rheumatoid arthritis.
    Keystone EC; Haraoui B; Bykerk VP
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S200-2. PubMed ID: 14969078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clarithromycin in patients with active rheumatoid arthritis.
    Ogrendik M
    Curr Med Res Opin; 2007 Mar; 23(3):515-22. PubMed ID: 17355733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
    Genovese MC; Kaine JL; Lowenstein MB; Del Giudice J; Baldassare A; Schechtman J; Fudman E; Kohen M; Gujrathi S; Trapp RG; Sweiss NJ; Spaniolo G; Dummer W;
    Arthritis Rheum; 2008 Sep; 58(9):2652-61. PubMed ID: 18759293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.
    Klarenbeek NB; van der Kooij SM; Güler-Yüksel M; van Groenendael JH; Han KH; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Feb; 70(2):315-9. PubMed ID: 21068104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.
    Lovell DJ; Ruperto N; Goodman S; Reiff A; Jung L; Jarosova K; Nemcova D; Mouy R; Sandborg C; Bohnsack J; Elewaut D; Foeldvari I; Gerloni V; Rovensky J; Minden K; Vehe RK; Weiner LW; Horneff G; Huppertz HI; Olson NY; Medich JR; Carcereri-De-Prati R; McIlraith MJ; Giannini EH; Martini A; ;
    N Engl J Med; 2008 Aug; 359(8):810-20. PubMed ID: 18716298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: Results of the Dose-Ranging Assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial.
    Mease PJ; Revicki DA; Szechinski J; Greenwald M; Kivitz A; Barile-Fabris L; Kalsi J; Eames J; Leirisalo-Repo M
    J Rheumatol; 2008 Jan; 35(1):20-30. PubMed ID: 18050385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis.
    Bartelds GM; Wijbrandts CA; Nurmohamed MT; Stapel S; Lems WF; Aarden L; Dijkmans BA; Tak PP; Wolbink GJ
    Ann Rheum Dis; 2007 Jul; 66(7):921-6. PubMed ID: 17301106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis.
    den Broeder A; van de Putte L; Rau R; Schattenkirchner M; Van Riel P; Sander O; Binder C; Fenner H; Bankmann Y; Velagapudi R; Kempeni J; Kupper H
    J Rheumatol; 2002 Nov; 29(11):2288-98. PubMed ID: 12415583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial.
    Lodder MC; Van Pelt PA; Lems WF; Kostense PJ; Koks CH; Dijkmans BA
    J Rheumatol; 2003 Sep; 30(9):2080-1. PubMed ID: 12966622
    [No Abstract]   [Full Text] [Related]  

  • 19. The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease.
    Cutolo M
    Clin Exp Rheumatol; 2004; 22(2):144. PubMed ID: 15083879
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
    Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
    Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.